China Universal Asset Management »

Eyepoint Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $108k 15k 7.45
2024-09-30 $82k 10k 7.99
2024-06-30 $53k 6.1k 8.70
2024-03-31 $194k 9.4k 20.67
2023-12-31 $94k 4.1k 23.11
2022-09-30 $3.0k 319 9.40

More positions owned by China Universal Asset Management

Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Alphabet Inc-cl A Common Stock (GOOGL)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Tesla Common Stock (TSLA)
Regeneron Pharmaceuticals Common Stock (REGN)
Netflix Common Stock (NFLX)
Taiwan Semiconductor-sp Adr (TSM)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
Adage Capital Partners GP
BlackRock
Franklin Resources
Vanguard Group
Federated Investors
TCG Crossover Management
RA Capital Management
Citadel Advisors
T. Rowe Price Associates
Goldman Sachs Group
Geode Capital Management
Perceptive Advisors
State Street Corporation

View all funds holding Eyepoint Pharmaceuticals